Navigation Links
Anpac Bio-Medical Presents 'Cancer Differentiation Analysis' Research at Nobel Laureate Cancer Research Summit

SACRAMENTO, Calif., May 13, 2015 /PRNewswire/ -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu this week presented what event organizers published as, "very promising" and "breakthrough" early cancer detection technology research results at the "2015 Nobel Prize Laureate Summit on Biomedical Science: Frontiers in Cancer Research" (NPLS) in Tianjin, China.

The NPLS was the first meeting of five Nobel Laureate Prize winners and the 20 top cancer researchers in the world, gathering for an unprecedented exchange of research results and advances related to cancer identification, diagnosis, and treatment.

An accomplished inventor with over 200 patent applications (100 related to leading-edge cancer research/diagnostics), as well as a member of the American Society of Clinical Oncologists (ASCO), Dr. Yu was welcomed by Summit organizers to share Anpac's innovative "Cancer Differentiation Analysis" (CDA) technology results; revealing Anpac's CDA effectively reinventing cancer screening and early cancer detection, through simple, standard, non-invasive blood tests – known as "Blood Biopsies"-- and Anpac CDA medical devices.

Anpac's CDA technology essentially executes for patients and doctors "Blood Biopsies", which research reveals quickly, efficiently, and dramatically improves cancer detection sensitivity and specificity-- without producing any side effects in patients.

In other words, Anpac's CDA diagnostics can identify threatening cancer cells – and the type of cancer cells (or where they are located in the body) – often before those cells become or grow into Stage 1+ tumors (or potentially even forming into tumors in the first place).

Comprehensive research validity data from nearly 20,000 cases indicate Anpac's CDA diagnostics far exceed existing or competing technologies - revealing a sensitivity and specificity rate range of 70%-85% for over ten different types of cancer, with the ability of early stage detection for most of them.

NPLS organizers list the outline of Dr. Yu's research in the Nobel Prize Laureate Summit Research Paper Compilation as: A New Generation Cancer Diagnostic Technology with High Sensitivity and Specificity, Fast Detection Speed, No Side Effects, Ability for Early Diagnosis, and Cost Efficiency.  And it concludes the research summary with, "CDA technology is a game-changing, effective approach in detecting a number of cancer sites at an early stage with the potential to resolve several existing issues in the field of cancer diagnostics."

For further information:; or Anpac Bio-Medical Science Company, Ltd.:

Photo -

Photo -


SOURCE Anpac Bio-Medical Science Company, Ltd.
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. TissueGene, Inc. Presents Phase 2 Data for Its Novel Cell Therapy for the Treatment of Osteoarthritis of the Knee
2. Paradigm CEO Dr. Robert Penny Presents Keynote Address at 2015 ISBER Conference
3. Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors
4. DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083s Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM)
5. Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform
6. Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015
7. Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th
8. Resverlogix Presents at the Prestigious American College of Cardiology 64th Annual Scientific Session & Expo (ACC.15)
9. At London Predictive Toxicology Summit Asymmetrex Presents New Biotech Solutions For Earlier Identification Of Drugs Toxic To Patients’ Adult Stem Cells
10. Dr. Sanford Silverman Presents Correlation of Genetics and Pain Management on Behalf of Proove Biosciences, Inc.
11. ASBM Presents European Physicians Survey at Spanish Ministry of Health
Post Your Comments:
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel is the ... Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are among ... Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel is a market leader ...
(Date:7/2/2019)... POWAY, Calif. (PRWEB) , ... July 02, 2019 , ... ... new documentary entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on ... and wild animals. Animal Pharm was recently included in the Brentwood ...
(Date:6/12/2019)... ... June 12, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is ... signed. The agreement will grant exclusive rights for Zillion to represent LDA in ...
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... engagement, and Carilion Clinic, a national leader in opioid treatment, announced today they ... care. , Mytonomy recently deployed its virtual care platform at the ...
Breaking Biology Technology:
(Date:7/9/2019)... ... July 09, 2019 , ... Murrieta Genomics, a ... incubator program. The founder and CEO of Tx Genetic, Helen Harrison, has spent ... suffering from epithelial connective tissue disorders. , “We are pleased and excited to ...
(Date:6/27/2019)... ... ... Lighting designers from integrated design firm LPA recently earned two ... both engaging and energy efficient lighting systems. , The lighting for the repositioning of ... California earned an IES Illumination Award of Merit in the Energy and Environment category. ...
(Date:6/19/2019)... ... June 19, 2019 , ... Dahryn Trivedi, today released research results ... Sodium, antibiotic which can prove to be beneficial for treating multiple bacterial diseases. , ... amount , Over 68% decrease in weight , Over ...
Breaking Biology News(10 mins):